Table 3 Drug-Related Time Distribution of Drug-Related Conjunctivitis Caused by Different Drugs.

From: Real-World pharmacovigilance analysis of drug-related conjunctivitis using the FDA adverse event reporting system database

Classification

Drug

Mean (day)

Q1 (day)

Q3 (day)

BCPNN

Non-Ophthalmic Drugs

Latanoprost

364.86

9.50

130.50

3.39

Non-Ophthalmic Drugs

Canakinumab

340.42

98.75

395.00

2.16

Non-Ophthalmic Drugs

Dupilumab

145.56

0

111.25

3.56

Non-Ophthalmic Drugs

Erlotinib

108.62

20.00

121.00

1.69

Non-Ophthalmic Drugs

Tralokinumab

101.40

10.00

180.00

6.32

Non-Ophthalmic Drugs

Cetuximab

64.50

23.75

91.50

2.30

Non-Ophthalmic Drugs

Allopurinol

14.09

12.00

20.00

2.32

Ophthalmic Remedy

Brimonidine

273.90

21.50

266.50

4.50

Ophthalmic Remedy

Lamotrigine

26.71

9.00

20.75

2.07